Tissue Regenix Group plc (TRX.L)
GBp 36.4
(-0.27%)
GBp 36.4
(-0.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.71 Million GBP | 37.01% |
| 2022 | -2.18 Million USD | 37.21% |
| 2021 | -3.48 Million USD | 64.11% |
| 2020 | -9.7 Million GBP | -39.24% |
| 2019 | -6.97 Million GBP | 14.82% |
| 2018 | -8.18 Million GBP | 11.22% |
| 2017 | -9.22 Million GBP | 13.63% |
| 2016 | -10.67 Million GBP | 20.34% |
| 2015 | -13.4 Million GBP | -76.78% |
| 2014 | -7.58 Million GBP | 17.83% |
| 2013 | -9.22 Million GBP | -66.98% |
| 2012 | -5.52 Million GBP | -30.95% |
| 2011 | -4.21 Million GBP | 50.87% |
| 2010 | -8.58 Million GBP | -2268.16% |
| 2009 | -362.65 Thousand GBP | 89.28% |
| 2008 | -3.38 Million GBP | -2601.37% |
| 2007 | -125.27 Thousand GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -222.17 Thousand GBP | 0.0% |
| 2023 Q4 | -643.23 Thousand GBP | 0.0% |
| 2023 Q2 | -724.14 Thousand GBP | 0.0% |
| 2023 FY | -1.37 Million GBP | 37.01% |
| 2022 FY | -2.18 Million USD | 37.21% |
| 2022 Q4 | -929.07 Thousand GBP | 0.0% |
| 2022 Q2 | -1.23 Million GBP | 0.0% |
| 2021 Q2 | -1.67 Million GBP | 0.0% |
| 2021 FY | -3.48 Million USD | 64.11% |
| 2020 FY | -9.7 Million GBP | -39.24% |
| 2020 Q4 | -7.36 Million GBP | 0.0% |
| 2020 Q2 | -2.34 Million GBP | 0.0% |
| 2019 Q2 | -4.05 Million GBP | 0.0% |
| 2019 Q4 | -2.91 Million GBP | 0.0% |
| 2019 FY | -6.97 Million GBP | 14.82% |
| 2018 Q4 | -3.74 Million GBP | 0.0% |
| 2018 FY | -8.18 Million GBP | 11.22% |
| 2017 FY | -9.22 Million GBP | 13.63% |
| 2016 FY | -10.67 Million GBP | 20.34% |
| 2015 FY | -13.4 Million GBP | -76.78% |
| 2014 FY | -7.58 Million GBP | 17.83% |
| 2013 FY | -9.22 Million GBP | -66.98% |
| 2012 Q3 | -671.75 Thousand GBP | 0.0% |
| 2012 Q2 | -671.75 Thousand GBP | 0.0% |
| 2012 Q1 | -671.75 Thousand GBP | 0.0% |
| 2012 FY | -5.52 Million GBP | -30.95% |
| 2012 Q4 | -874.5 Thousand GBP | -30.18% |
| 2011 Q1 | -1.35 Million GBP | 0.0% |
| 2011 FY | -4.21 Million GBP | 50.87% |
| 2011 Q4 | -671.75 Thousand GBP | 50.49% |
| 2011 Q3 | -1.35 Million GBP | 0.0% |
| 2011 Q2 | -1.35 Million GBP | 0.0% |
| 2010 FY | -8.58 Million GBP | -2268.16% |
| 2010 Q2 | -30 Thousand GBP | 0.0% |
| 2010 Q4 | -1.35 Million GBP | -4422.5% |
| 2010 Q3 | -30 Thousand GBP | 0.0% |
| 2010 Q1 | -30 Thousand GBP | 0.0% |
| 2009 Q1 | -538 Thousand GBP | 0.0% |
| 2009 Q4 | -30 Thousand GBP | 94.42% |
| 2009 Q2 | -538 Thousand GBP | 0.0% |
| 2009 FY | -362.65 Thousand GBP | 89.28% |
| 2009 Q3 | -538 Thousand GBP | 0.0% |
| 2008 FY | -3.38 Million GBP | -2601.37% |
| 2008 Q4 | -538 Thousand GBP | -3315.87% |
| 2008 Q2 | -15.75 Thousand GBP | 0.0% |
| 2008 Q1 | -15.75 Thousand GBP | 0.0% |
| 2008 Q3 | -15.75 Thousand GBP | 0.0% |
| 2007 Q1 | - GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 Q3 | - GBP | 0.0% |
| 2007 Q4 | -15.75 Thousand GBP | 0.0% |
| 2007 FY | -125.27 Thousand GBP | 0.0% |
| 2006 Q4 | - GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|